Variant report
Variant | nsv593725 |
---|---|
Chromosome Location | chr4:10397327-10402767 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:10184632..10187184-chr4:10400763..10402949,2 | K562 | blood: | |
2 | chr4:10390019..10393146-chr4:10400722..10404569,4 | K562 | blood: | |
3 | chr4:10185450..10187184-chr4:10401056..10402949,2 | K562 | blood: | |
4 | chr4:10391155..10393700-chr4:10401011..10403355,4 | MCF-7 | breast: | |
5 | chr4:10181802..10184742-chr4:10401642..10403855,2 | K562 | blood: | |
6 | chr4:10120437..10124442-chr4:10402726..10405362,4 | K562 | blood: | |
7 | chr4:10180539..10184306-chr4:10401076..10403855,3 | K562 | blood: | |
8 | chr4:10117259..10123841-chr4:10401893..10417202,19 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000071127 | chromatin interactions |
ENSG00000223086 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6835730 | chr4:10397327-10397328 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs185129134 | chr4:10397370-10397371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs546736916 | chr4:10397396-10397397 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546864113 | chr4:10397414-10397415 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs376027426 | chr4:10397491-10397492 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568181364 | chr4:10397560-10397561 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs535293292 | chr4:10397616-10397617 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568432308 | chr4:10397626-10397627 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs112805002 | chr4:10397665-10397666 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs146836643 | chr4:10397682-10397683 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539046095 | chr4:10397685-10397686 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs73809406 | chr4:10397756-10397757 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs572857591 | chr4:10397758-10397759 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112262683 | chr4:10397785-10397786 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553504773 | chr4:10397815-10397816 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575064749 | chr4:10397884-10397885 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs542477205 | chr4:10397895-10397896 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs563966372 | chr4:10397917-10397918 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs576010075 | chr4:10397937-10397938 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546178210 | chr4:10397943-10397944 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs191219754 | chr4:10397991-10397992 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs528555154 | chr4:10397999-10398000 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546753194 | chr4:10398012-10398013 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs562242591 | chr4:10398014-10398015 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550956813 | chr4:10398049-10398050 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569240782 | chr4:10398052-10398053 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs139370212 | chr4:10398091-10398092 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567113685 | chr4:10398098-10398099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs568767849 | chr4:10398101-10398102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs150043398 | chr4:10398137-10398138 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs551323341 | chr4:10398162-10398163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs566368109 | chr4:10398225-10398226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs183341985 | chr4:10398259-10398260 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539954324 | chr4:10398266-10398267 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555155870 | chr4:10398280-10398281 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs573826675 | chr4:10398302-10398303 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs536009098 | chr4:10398309-10398310 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs115374903 | chr4:10398329-10398330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs575975974 | chr4:10398332-10398333 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187638630 | chr4:10398370-10398371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs564826794 | chr4:10398371-10398372 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs573137198 | chr4:10398402-10398403 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs4389568 | chr4:10398427-10398428 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs373123473 | chr4:10398444-10398445 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs561845748 | chr4:10398461-10398462 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs191502423 | chr4:10398481-10398482 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs573043557 | chr4:10398511-10398512 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs145399721 | chr4:10398589-10398590 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs533666733 | chr4:10398599-10398600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs4698048 | chr4:10398635-10398636 | Weak transcription Enhancers Bivalent/Poised TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 16272173 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21509527 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Schizophrenia | 22241247 | CNVD |
Autosomal-dominant microtia | 18179897 | CNVD |
Glioma | 17123091 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neuroblastoma | 20406844 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:10387000-10403600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr4:10396800-10399600 | Enhancers | HMEC | breast |
3 | chr4:10397000-10399000 | Enhancers | NHEK | skin |
4 | chr4:10397000-10400000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr4:10397200-10399200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr4:10397400-10398400 | Enhancers | K562 | blood |
7 | chr4:10397600-10399000 | Enhancers | Fetal Thymus | thymus |
8 | chr4:10397800-10398400 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
9 | chr4:10398400-10403400 | Weak transcription | K562 | blood |
10 | chr4:10398600-10398800 | Bivalent/Poised TSS | Skeletal Muscle Male | skeletal muscle |
11 | chr4:10399000-10405600 | Weak transcription | NHEK | skin |
12 | chr4:10399200-10402800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
13 | chr4:10399600-10400000 | Weak transcription | HMEC | breast |
14 | chr4:10400000-10400400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
15 | chr4:10400000-10400600 | Enhancers | HMEC | breast |
16 | chr4:10400400-10400600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
17 | chr4:10400600-10405200 | Weak transcription | HMEC | breast |
18 | chr4:10400600-10405400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |